MTNB
AMEX · Biotechnology
Matinas Biopharma Holdings I
$0.57
+0.01 (+1.41%)
Open$0.60
Previous Close$0.56
Day High$0.60
Day Low$0.57
52W High$3.09
52W Low$0.47
Volume—
Avg Volume20.6K
Market Cap3.82M
P/E Ratio—
EPS$-3.54
SectorBiotechnology
Analyst Ratings
Strong Sell
7 analysts
Price Target
+6,817.0% upside
Current
$0.57
$0.57
Target
$39.33
$39.33
$22.47
$39.33 avg
$48.65
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 545.4K | 506.2K | 440.2K |
| Net Income | -151,735 | -126,413 | -142,621 |
| Profit Margin | -27.8% | -25.0% | -32.4% |
| EBITDA | -193,711 | -167,268 | -163,365 |
| Free Cash Flow | -191,504 | -185,587 | -103,932 |
| Rev Growth | -0.1% | +13.2% | +21.4% |
| Debt/Equity | 0.35 | 0.35 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |